Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
Errata to this article were published (J Clin Endocrinol Metab, 18 Feb 2025 ↗ · 15 Jul 2025 ↗)
Methodological detailsGRADE methodology, systematic reviews, multidisciplinary panel
- GRADE methodology
- Systematic reviews
- Multidisciplinary panel
Recommendations
As issued by the authors
Suggests empiric vitamin D supplementation for children and adolescents aged 1 to 18 years to prevent nutritional rickets and for its potential to lower the risk of respiratory tract infections
Suggests empiric vitamin D supplementation for those aged 75 years and older for its potential to lower the risk of mortality
Suggests empiric vitamin D supplementation in pregnancy for its potential to lower the risk of preeclampsia, intra-uterine mortality, preterm birth, SGA birth and neonatal mortality
Suggests empiric vitamin D supplementation for those with high-risk prediabetes for its potential to reduce progression to diabetes
For nonpregnant people older than 50 years for whom vitamin D is indicated, suggests daily vitamin D rather than intermittent high doses
Suggests against empiric vitamin D supplementation above the current Dietary Reference Intakes (DRI) to lower the risk of disease in healthy adults younger than 75 years
Suggests against routine 25(OH)D testing in all populations considered
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →